{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/202043637"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Although African-Americans often require higher doses of erythropoiesis-stimulating agents, this may result from late treatment initiation, lower hemoglobin levels, or the presence of comorbidities such as diabetes and inflammation, although racial differences in response cannot be excluded." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "pubmedcentralcanada.ca" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/59459230"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/202043637"] } } }
